Prof. Kim Tae-jung is the Head of the Pathology department at Yeouido St. Mary’s hospital in South Korea. He is a member of pathology committee at International Association for the Study of Lung Cancer (IASLC) and a vice chairman of Tumor Immunology Multidisciplinary Research group at Korea Association of Lung Cancer (KALC). He organizes many biomarker studies and trials and subsequent platform settings in South Korea and Asia. His major academic interests include cancer genomics, biomarkers, analytic test platforms, target therapy and companion diagnostics and immunotherapy.

After earning a PhD in Phytopathology from the University of Constance, Wolfgang has accumulated over 25 years of experience in the biotech industry. Throughout his career, he has taken on diverse roles in sales and marketing within the life science and diagnostics sectors. Currently, Wolfgang holds the position of VP of Life Science Marketing and Sales at QIAGEN, where he leads strategic initiatives to drive growth and impact in the market.

Ellen completed her PhD in Bern, Switzerland, focussing on the role of thiomodifications in tRNA import into the mitochondria of Trypanosoma brucei. During several years as a post-doctoral fellow at the Institute of Tropical Medicine in Tuebingen, Germany, she investigated the molecular mechanisms and pathogen-host interactions in the causative organisms of malaria and tuberculosis, and worked in clinical study teams in malaria vaccine trials in Germany and Gabon. Ellen is currently a Global Product Manager for digital PCR at QIAGEN.

Eva holds a PhD in Microbiology from the Friedrich-Alexander University Erlangen-Nuremberg. Before joining QIAGEN, Eva worked as a postdoctoral fellow at Tufts University School of Medicine in Boston, MA, USA. Eva is currently an Associate Director at QIAGEN, where her team is responsible for sample technology product development, including solutions for manual and automated extraction from a wide range of sample materials including FFPE tissue samples. Since joining the QIAGEN R&D team in Hilden in 2012, Eva’s work also included sample preparation for microbiome and liquid biopsy applications.

Ronny received his PhD in the field of molecular plant-pathogen interaction at the MPI for Terrestrial Microbiology in Marburg and at the Ruhr-University Bochum (Germany). After several international projects in Germany and the UK focusing on microbiology, molecular biology and NGS data analysis, he joined QIAGEN in August 2020. Since then, he has been involved in the development of the digital PCR assay portfolio, including applications for pathogen detection. He is currently a Senior Scientist in Research and Development and works on the development of digital PCR assays at QIAGEN.